Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-26-002644
Filing Date
2026-04-03
Accepted
2026-04-03 11:58:23
Documents
86
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR DEC 2025 sunshine_i10k-123125.htm   iXBRL 10-K 1079582
2 CONSENT OF BUSH & ASSOCIATES CPA LLC sunshine_ex2301.htm EX-23.1 4295
3 CONSENT OF M&K CPAS, PLLC sunshine_ex2302.htm EX-23.2 3862
4 CERTIFICATION sunshine_ex3101.htm EX-31.1 10483
5 CERTIFICATION sunshine_ex3102.htm EX-31.2 10480
6 CERTIFICATION sunshine_ex3201.htm EX-32.1 5129
12 GRAPHIC image_001.jpg GRAPHIC 6215
13 GRAPHIC image_003.jpg GRAPHIC 14603
14 GRAPHIC bushheader.jpg GRAPHIC 11570
15 GRAPHIC image_002.jpg GRAPHIC 7467
  Complete submission text file 0001683168-26-002644.txt   5623932

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE sbfm-20251231.xsd EX-101.SCH 43956
8 XBRL CALCULATION FILE sbfm-20251231_cal.xml EX-101.CAL 66533
9 XBRL DEFINITION FILE sbfm-20251231_def.xml EX-101.DEF 138037
10 XBRL LABEL FILE sbfm-20251231_lab.xml EX-101.LAB 363655
11 XBRL PRESENTATION FILE sbfm-20251231_pre.xml EX-101.PRE 303584
90 EXTRACTED XBRL INSTANCE DOCUMENT sunshine_i10k-123125_htm.xml XML 723347
Mailing Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301
Business Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301 954-330-0684
Sunshine Biopharma Inc. (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41282 | Film No.: 26837255
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)